An F.D.A. advisory panel dealt a setback to those seeking treatment for PTSD, citing health risks of the illegal drug and study flaws. Psychedelic and Hallucinogenic Drugs, Drug Abuse and Traffic, Post-Traumatic Stress Disorder, Mental Health and Disorders, Drugs (Pharmaceuticals), Ecstasy (Drug), Regulation and Deregulation of Industry, Drug Enforcement Administration, Food and Drug Administration, Lykos Therapeutics, Multidisciplinary Assn for Psychedelic Studies An F.D.A. advisory panel dealt a setback to those seeking treatment for PTSD, citing health risks of the illegal drug and study flaws. NYT > Business
Headlines
